Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma

NCT07661771 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

568

Enrollment

OTHER

Sponsor class

Conditions

Non-metastatic Nasopharyngeal Carcinoma

Interventions

PROCEDURE: Comprehensive Therapy Based on Tumor Stage
RADIATION: IMRT with Primary Clinical Target Volume Based on Margin Expansion
RADIATION: IMRT with Consensus Primary Clinical Target Volume

Sponsor

Sun Yat-sen University